The purpose of this study was to prepare prolonged release tablets of verapamil: matrix and coated tablets, because of the importance of these systems in drug delivery and improving the patient compliance and therapeutic efficacy .Different formula
tions were prepared by using different release-modifiers polymers (EURL100 and EURS100). Direct compression technique was used to prepare coated tablets while matrix tablets were prepared by wet granulation and direct compression methods. The prepared formulations were evaluated in terms of their precompression parameters, physical characteristics, dissolution test and in vitro drug release kinetic studies. The results showed that matrix tablets containing 7.5or10% of EuRS100 and EuRL100 respectively and that coated tablets prepared by using coating solution (15%) which was applied about 120(in case of EuRS100) or 280 (in case of EuRL100) times were the best. These tablets released about 90-95% of verapamil within 24h
The present study aims to develop sustained release (SR) matrix tablets of methyldopa using
hydrophilic hydroxypropyl methylcellulose (HPMC), and to study the effect of some formulation
variables (HPMC concentration and viscosity grade, combination
with hydrophobic Ethylcellulose
(EC) in different ratio, binder and lubricants concentrations) on the properties of prepared tablets.
Matrix tablets were prepared by wet granulation method, and prepared granules and tablets were
subjected to suitable physiochemical studies. Drug release kinetics showed that drug release
mechanism for about all formulations was found to fit best to Higuchi model and drug release
mechanism was anomalous diffusion based on release exponent value. The in-vitro dissolution
studies showed that formulation F6 containing 15% of HPMC K100M and formulation F11
containing EC:HPMC K4M (5%:10%) were able to sustain the release of methyldopa up to 24 hours
so these two formulations were selected as suitable formulations.
The objective of the present study was to formulate methyldopa sustained release
matrix tablets using hydrophilic hydroxypropyl methylcellulose (HPMC) alone or in
combination with hydrophobic ethyl cellulose polymer(EC). Matrix tablets were prepare
d
by wet granulation method, and subjected to physiochemical studies. All formulations
showed physiochemical properties which appear to be in compliance with pharmacopeial
standards. The in-vitro dissolution studies showed that increase in concentration or
viscosity of HPMC polymer led to decrease in the rate of drug release decreased. The
results also revealed that Combination of HPMC K4M and EC slower drug release more
than using HPMC K4M alone. Drug release kinetics of about all formulations correspond
best to Korsemeyer-Peppas model and drug release mechanism was anomalous diffusion
based on release exponent value.
The aim of the present study is to prepare extended hard capsules of furosemide using
Eudragit RL, Eudragit RS and Ethyl cellulose individually and in different ratios (6,8,12 and
15%). The granules were prepared by wet granulation using isopropyl
alcohol as a
granulating agent and then filled into capsules. The influence of different concentrations and
type of polymer was studied. The prepared capsules assessed for their physicochemical
properties and in-vitro drug release studies. In vitro release data show that Ethyl cellulose
has more retardation than Eudragits, and Eudragit RS retards drug more than Eudragit RL
does. Furthermore, higher concentration of polymer tends to more retardation than lower
concentration.